Healthcare stocks are lower with the NYSE Healthcare Sector Index declining about 0.4% while shares of healthcare companies in the S&P 500 slipping 0.8% as a group.
In company news, CEL-SCI Corp. ( CVM ) is up 1.7% at $1.23 a share, giving back roughly half of its earlier gains after this morning saying it has signed a Cooperative Research and Development Agreement with the Naval Medical Center in San Diego for Phase I testing of the company's investigational Leukocyte Interleukin injection in HIV/HPV co-infected men and women with peri-anal warts.
CVM will contribute the investigational study drug Multikine and will retain all rights to any currently owned technology and will have the right to exclusively license any new technology developed from the collaboration.
In other sector news,
(+) CTIC, Reaches deal with FDA for a Special Protocol Assessment for Phase III testing of its pacritinib drug candidate in patients with myelofibrosis.
(-) ATOS, Voluntarily recalls its ForeCYTE Breast Health Test and the Mammary Aspiration Specimen Cytology Test to "address concerns raised by the FDA."
Copyright (C) 2016 MTNewswires.com. All rights reserved. Unauthorized reproduction is strictly prohibited.